← Back to All US Stocks

Teleflex Inc. (TFX) Fundamental Analysis & AI Grade 2026

TFX NYSE Surgical & Medical Instruments & Apparatus DE CIK: 0000096943
Update Pending • Analysis: May 9, 2026 • SEC Data: 2026-03-31
Combined AI Grade
C
80% Confidence
STRONG AGREEMENT
C
75% Conf
C
84% Conf

📊 TFX Key Takeaways

Revenue: $548.3M
Net Margin: -1.5%
Free Cash Flow: N/A
Current Ratio: 2.55x
Debt/Equity: 0.82x
EPS: $-0.18
AI Grade: C with 75% confidence
Teleflex Inc. (TFX) receives a C fundamental grade with 80% confidence from our AI analysis based on SEC 10-K filings. With revenue of $548.3M, net profit margin of -1.5%, and return on equity (ROE) of -0.3%, Teleflex Inc. demonstrates mixed fundamentals in the Healthcare sector. Below is our complete TFX stock analysis for 2026.

Is Teleflex Inc. (TFX) a Good Investment?

Claude

Despite strong revenue growth of 17.2%, Teleflex is currently unprofitable with a net loss of $8.2M and critically weak interest coverage of 0.5x, indicating it cannot service its $2.5B debt from operating income. The 56.1% gross margin indicates healthy product economics, but operating expenses are severely constraining profitability, creating unsustainable financial distress.

ChatGPT

Teleflex shows solid top-line growth and healthy gross profitability, but the latest period’s fundamentals are dominated by a severe collapse in earnings, with net income deeply negative and margins compressing sharply below the gross profit line. Liquidity appears adequate and leverage is not extreme, but weak interest coverage and the absence of operating cash flow visibility make the current growth profile look low quality until profitability normalizes.

Teleflex Inc. Key Strengths (TFX)

Claude
  • + Strong revenue growth of 17.2% YoY demonstrates market demand for products
  • + Healthy gross margin of 56.1% indicates pricing power and efficient production costs
  • + Strong liquidity position with current ratio of 2.55x and quick ratio of 2.03x provides near-term financial flexibility
ChatGPT
  • + Revenue growth of 17.2% YoY indicates continued demand and business momentum
  • + Gross margin of 56.2% suggests strong product economics and pricing power at the gross profit level
  • + Current ratio of 2.54x and quick ratio of 2.01x indicate solid near-term liquidity

TFX Stock Risks: Teleflex Inc. Investment Risks

Claude
  • ! Interest coverage of 0.5x is critically weak; operating income cannot cover interest expense, making debt unsustainable
  • ! Currently unprofitable with net loss of $8.2M and negative net margin of -1.5%, indicating fundamental operational problems
  • ! Operating margin of only 3.7% despite 56.1% gross margin reveals severe operating expense issues that are not being controlled
  • ! Long-term debt of $2.5B is substantial relative to current earnings capacity and creates leverage risk
  • ! Missing operating cash flow and free cash flow data prevents assessment of actual cash generation ability
ChatGPT
  • ! Net margin of -45.4% and net loss of $905.64M signal severe earnings deterioration
  • ! Operating margin of 5.9% shows weak conversion of revenue into operating profit despite strong gross margin
  • ! Interest coverage of 2.7x and long-term debt of $2.64B limit financial flexibility if profitability remains pressured

Key Metrics to Watch

Claude
  • * Operating income and operating margin trajectory - must improve significantly to justify debt load
  • * Interest coverage ratio - must return above 1.0x for financial stability
  • * Operating and free cash flow - critical to validate actual cash generation and debt servicing capability
  • * Net income and path to profitability - company must eliminate losses
  • * Operating expense ratio relative to revenue - identify drivers of margin compression
ChatGPT
  • * Operating margin recovery and normalization of net income
  • * Operating cash flow and free cash flow generation

Teleflex Inc. (TFX) Financial Metrics & Key Ratios

Revenue
$548.3M
Net Income
$-8.2M
EPS (Diluted)
$-0.18
Free Cash Flow
N/A
Total Assets
$6.8B
Cash Position
$309.4M

💡 AI Analyst Insight

Strong liquidity with a 2.55x current ratio provides a solid financial cushion.

TFX Profit Margin, ROE & Profitability Analysis

Gross Margin 56.1%
Operating Margin 3.7%
Net Margin -1.5%
ROE -0.3%
ROA -0.1%
FCF Margin N/A

TFX vs Healthcare Sector: How Teleflex Inc. Compares

How Teleflex Inc. compares to Healthcare sector averages

Net Margin
TFX -1.5%
vs
Sector Avg 12.0%
TFX Sector
ROE
TFX -0.3%
vs
Sector Avg 15.0%
TFX Sector
Current Ratio
TFX 2.6x
vs
Sector Avg 2.0x
TFX Sector
Debt/Equity
TFX 0.8x
vs
Sector Avg 0.6x
TFX Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

Is Teleflex Inc. Stock Overvalued? TFX Valuation Analysis 2026

Based on fundamental analysis, Teleflex Inc. shows some fundamental concerns relative to the Healthcare sector in 2026.

Return on Equity
-0.3%
Sector avg: 15%
Net Profit Margin
-1.5%
Sector avg: 12%
Revenue Growth
N/A
Year-over-year
Debt/Equity
0.82x
Sector avg: 0.6x

Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.

Teleflex Inc. Balance Sheet: TFX Debt, Cash & Liquidity

Current Ratio
2.55x
Quick Ratio
2.03x
Debt/Equity
0.82x
Debt/Assets
54.5%
Interest Coverage
0.46x
Long-term Debt
$2.5B

TFX Revenue & Earnings Growth: 5-Year Financial Trend

TFX 5-year financial data: Year 2021: Revenue $2.8B, Net Income $461.5M, EPS $9.80. Year 2022: Revenue $2.8B, Net Income $335.3M, EPS $7.09. Year 2023: Revenue $3.0B, Net Income $485.4M, EPS $10.23. Year 2024: Revenue $3.0B, Net Income $363.1M, EPS $7.68. Year 2025: Revenue $2.0B, Net Income $356.3M, EPS $7.53.
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: Teleflex Inc.'s revenue has declined by 29% over the 5-year period, indicating business contraction. The most recent EPS of $7.53 reflects profitable operations.

TFX Revenue Growth, EPS Growth & YoY Performance

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
N/A
Free cash flow / Revenue

TFX Quarterly Earnings & Performance

Quarterly financial performance data for Teleflex Inc. including revenue, net income, and earnings per share.
Quarter Revenue Net Income EPS
Q1 2026 $414.3M -$8.2M $-0.18
Q3 2025 $764.4M $15.3M $2.36
Q2 2025 $749.7M $15.3M $1.69
Q1 2025 $700.7M $15.3M $0.32
Q3 2024 $746.4M $15.3M $2.36
Q2 2024 $743.3M $15.3M $1.69
Q1 2024 $710.9M $15.3M $0.32
Q3 2023 $686.8M $76.7M $2.16

Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.

Teleflex Inc. Dividends, Buybacks & Capital Allocation

Capital Expenditures
$18.8M
Investment in assets
Dividends Paid
$15.1M
Returned to shareholders

TFX SEC Filings: Latest 10-K & 10-Q Analysis

Access official SEC EDGAR filings for Teleflex Inc. (CIK: 0000096943)

📋 Recent SEC Filings

Date Form Document Action
Jun 9, 2026 4 xslF345X06/wk-form4_1781051548.xml View →
Jun 9, 2026 4 xslF345X06/wk-form4_1781051491.xml View →
Jun 9, 2026 8-K tfx-20260608.htm View →
Jun 2, 2026 8-K d71849d8k.htm View →
Jun 1, 2026 8-K d126202d8k.htm View →

Frequently Asked Questions about TFX

What is the AI rating for TFX?

Teleflex Inc. (TFX) has a Combined AI Grade of C from Claude (C) and ChatGPT (C) with 80% combined confidence, based on fundamental analysis of SEC EDGAR filings.

What are TFX's key strengths?

Claude: Strong revenue growth of 17.2% YoY demonstrates market demand for products. Healthy gross margin of 56.1% indicates pricing power and efficient production costs. ChatGPT: Revenue growth of 17.2% YoY indicates continued demand and business momentum. Gross margin of 56.2% suggests strong product economics and pricing power at the gross profit level.

What are the risks of investing in TFX?

Claude: Interest coverage of 0.5x is critically weak; operating income cannot cover interest expense, making debt unsustainable. Currently unprofitable with net loss of $8.2M and negative net margin of -1.5%, indicating fundamental operational problems. ChatGPT: Net margin of -45.4% and net loss of $905.64M signal severe earnings deterioration. Operating margin of 5.9% shows weak conversion of revenue into operating profit despite strong gross margin.

What is TFX's revenue and growth?

Teleflex Inc. reported revenue of $548.3M.

Does TFX pay dividends?

Teleflex Inc. pays dividends, with $15.1M distributed to shareholders in the trailing twelve months.

Where can I find TFX SEC filings?

Official SEC filings for Teleflex Inc. (CIK: 0000096943) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is TFX's EPS?

Teleflex Inc. has a diluted EPS of $-0.18.

How is the AI analysis conducted?

Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.

What is TFX's fundamental grade?

Based on our AI fundamental analysis in June 2026, Teleflex Inc. has a C grade with 80% confidence. Review the strengths and risks sections above for full context. This is not investment advice.

Is TFX stock overvalued or undervalued?

Valuation metrics for TFX: ROE of -0.3% (sector avg: 15%), net margin of -1.5% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.

What is TFX's AI grade for 2026?

Our dual AI analysis gives Teleflex Inc. a combined C grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.

What is TFX's free cash flow?

Teleflex Inc.'s operating cash flow is N/A, with capital expenditures of $18.8M.

How does TFX compare to other Healthcare stocks?

Vs Healthcare sector averages: Net margin -1.5% (avg: 12%), ROE -0.3% (avg: 15%), current ratio 2.55 (avg: 2).

Top Rated Stocks
AAPL 92% MSFT 92% FAST 92% ANET 88% RDDT 88% KNSL 88% MGRE 88% FIZZ 88% AVGO 87% DECK 87%
Sector: All Healthcare Stocks →
Disclaimer: This analysis is generated by Claude AI (Anthropic) and ChatGPT (OpenAI) based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: May 9, 2026 | Data as of: 2026-03-31 | Powered by Claude AI